BARCLAYS PLC - GALENA BIOPHARMA INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2016$1,0001,700
+11233.3%
0.00%
Q2 2016$015
-96.3%
0.00%
Q1 2016$0410
+2633.3%
0.00%
Q4 2015$0
-100.0%
15
-98.2%
0.00%
Q3 2015$1,000
-66.7%
845
-72.7%
0.00%
Q2 2015$3,000
-25.0%
3,098
-22.0%
0.00%
Q1 2015$4,000
-60.0%
3,970
-58.6%
0.00%
Q4 2014$10,000
-73.7%
9,586
-50.7%
0.00%
Q3 2014$38,000
-53.1%
19,437
-27.7%
0.00%
Q2 2014$81,000
-91.7%
26,881
-94.5%
0.00%
-100.0%
Q1 2014$979,000
+382.3%
489,498
+863.7%
0.00%
Q4 2013$203,000
+434.2%
50,792
+173.4%
0.00%
Q3 2013$38,000
+280.0%
18,576
+324.0%
0.00%
Q2 2013$10,0004,3810.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 375,000$855,0000.93%
HIGHLAND CAPITAL MANAGEMENT LP 800,000$1,824,0000.12%
Alyeska Investment Group, L.P. 780,000$1,778,0000.07%
KMS FINANCIAL SERVICES, INC 119,500$272,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 539,150$1,229,0000.04%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 25,100$57,0000.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 349,400$793,000,0000.02%
COMPTON CAPITAL MANAGEMENT INC /RI 12,000$27,0000.02%
Diversified Trust Co 40,000$91,0000.01%
PITTENGER & ANDERSON INC 18,000$41,0000.01%
View complete list of GALENA BIOPHARMA INC shareholders